2019 annual financial data

Seres Therapeutics 2019 Financial results

Direct answer

Revenue was 34.51M USD.

Operating income was -71.88M USD and net income was -70.28M USD.
Operating cash flow was -76.52M USD.

Get free Seres Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
34.51M USD
Operating income
-71.88M USD
Net income
-70.28M USD
Operating cash flow
-76.52M USD